Seth L.
Investment Team·8VC
San Francisco, CA, United States
Seth Lieblich focuses on 8VC's Bio-IT investments, spanning therapeutics, tools, bio-infrastructure and broader applications of biology. He joined from Amgen's Business Development technology group, where he handled search and evaluation, transactions for platform technologies, and strategic academic partnerships. Earlier, he worked at ZS Associates and co-founded Protomer Technologies.
See the rest of Seth L.'s profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.